Quick Answer
Zivo Bioscience, Inc. reported Total Assets of $1.64 million for fiscal year 2024.
Zivo Bioscience, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2024 | $1.64M | +195.7% |
| 2023 | $555.7K | -73.8% |
| 2022 | $2.12M | -76.4% |
| 2021 | $8.99M | +3983.1% |
| 2020 | $220.2K | -40.4% |
| 2019 | $369.4K | -10.2% |
| 2018 | $411.5K | +23.8% |
| 2017 | $332.3K | -54.9% |
| 2016 | $737.3K | +914.4% |
| 2015 | $72.7K | -28.6% |
| 2014 | $101.9K | -95.3% |
| 2013 | $2.17M | +829.2% |
| 2012 | $234.0K | -49.5% |
| 2011 | $463.5K | +36.4% |
| 2010 | $339.9K | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $559.5K | +12.9% | -20.5% |
| June 30, 2025 | $703.3K | +22.2% | -47.2% |
| March 31, 2025 | $1.33M | +63.1% | -19.0% |
| December 31, 2024 | $1.64M | +195.7% | +231.6% |
| September 30, 2024 | $495.6K | -76.4% | -13.9% |
| June 30, 2024 | $575.6K | -19.0% | -29.5% |
| March 31, 2024 | $816.4K | -27.6% | +46.9% |
| December 31, 2023 | $555.7K | -73.8% | -73.6% |
- Zivo Bioscience, Inc. showed an increase of +195.7% in Total Assets compared to the prior fiscal year.
- Over the 2010–2024 period, Zivo Bioscience, Inc.’s total assets has grown by 383.4% (from $339.9 thousand to $1.64 million).
- The most recent figure is from Zivo Bioscience, Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 18, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: